Viromed Medical AG
4.76
EUR
0.00
(0.00%)
Share Statistics
As of December 31, 2025, Viromed Medical AG has 21.25M shares outstanding.
| Shares Outstanding | 21.25M |
Financial Position
As of December 31, 2025, Viromed Medical AG maintains a current ratio of 2.74, meaning it holds 2.7x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.74 |
| Quick Ratio | 0.18 |
| Debt / Equity | 0.08 |
Stock Price Statistics
EURAs of the close on October 22, 2026, Viromed Medical AG's stock has gained approximately 440.91% over the past 52 weeks. The 50-day moving average sits at 5.71, while the 200-day moving average is 6.26.
| 52-Week Price Change | 440.91% |
| 50-Day Moving Average | 5.71 |
| 200-Day Moving Average | 6.26 |
Balance Sheet
EURAs of December 31, 2025, Viromed Medical AG holds 364,071.90 in cash and equivalents against 8,654.91 in total debt, resulting in a net debt position of -350,901.99. Total book value stands at 10.47M, with working capital of 3.61M providing operational flexibility.
| Cash & Cash Equivalents | 364,071.90 |
| Total Debt | 8,654.91 |
| Net Debt | -350,901.99 |
| Equity (Book Value) | 10.47M |
| Book Value Per Share | 0.49 |
| Working Capital | 3.61M |